BPC 157 TB 500 Blend: One Vial or Two Vials? | telos rx
BPC-157 and TB-500 in two separate telos rx vials
← Back to blog
bpc 157 tb 500 blend

BPC 157 TB 500 Blend: One Vial vs Two, What Is Actually Known

By TelosRX Editorial Team Updated

A BPC 157 TB 500 blend puts both peptides in one vial, while the alternative is two separate vials given as one protocol. Neither format has published human data showing it is better, and there is no peer-reviewed stability data for the two peptides mixed together that we could verify. The real trade-off is convenience versus dosing flexibility and quality control. telos rx supplies its stack as two separate vials.

Also searched as: bpc 157 tb 500, bpc157 tb500 blend, wolverine blend, bpc-157 and tb-500 in one vial.

Look into the BPC 157 TB 500 blend and you will see two kinds of listings: one pre-mixed vial, or a pair of vials sold together. They sound interchangeable, but they raise different questions about stability, dosing and what is inside.

This guide is about the format question only. If you are still deciding whether you want the stack at all, start with our comparison of BPC-157 vs BPC-157 + TB-500. If you already know you want to talk to a provider about it, the BPC-157 + TB-500 stack page explains how telos rx prescribes it.

Want a licensed provider to decide whether the stack fits you? Start a short online intake, reviewed asynchronously with no scheduled appointment.

See if the BPC-157 + TB-500 stack is right for you

What a BPC 157 TB 500 blend actually is

A BPC 157 TB 500 blend is a single vial that contains two different synthetic peptides:

  • BPC-157, a 15-amino-acid peptide (pentadecapeptide) based on a sequence from a protein found in human gastric juice. It is studied in animals and cells for tendon, ligament, muscle and gut-lining models and for angiogenesis, the growth of new blood vessels.
  • TB-500, a short synthetic fragment based on the actin-binding region of thymosin beta-4 (Tβ4). Tβ4 itself is a 43-amino-acid protein that sequesters G-actin, the building block of the cell skeleton, as described in a 2005 review in Trends in Molecular Medicine. TB-500 is not the same molecule as full Tβ4.

The nickname "Wolverine" gets attached to both formats. A Wolverine blend usually means one pre-mixed vial; a Wolverine stack can mean either. The background on that nickname is in our Wolverine stack explainer.

Is a BPC 157 TB 500 blend stable? What is and is not known

What is known: peptides in solution can degrade over time, and how fast depends on the formulation, the pH, the diluent, the container, light, temperature and how often the vial is punctured. Our peptide reconstitution explainer covers why research vials involve this step and why a prescription that arrives ready to inject does not.

What is not known: we could not find any published, peer-reviewed study measuring how BPC-157 and TB-500 behave when they share one vial. That means nobody can honestly tell you, from the literature, that a BPC 157 TB 500 blend stays stable for a set number of days or that one peptide does not affect the other. Any seller quoting a specific shelf life for a mixed vial should be able to show where that number comes from.

Compatibility: two peptides, one solution

Compatibility is a separate question from stability. When two active ingredients share a container, a pharmacist considers whether they can sit together without precipitating, binding or degrading each other, and whether the combined concentration still allows an accurate dose of each. For this particular pair, those questions have not been answered in published research. That does not make a blend unsafe; it means the answer has to come from the preparing pharmacy, not a product page.

One vial vs two vials: convenience and dosing flexibility

How the two formats compare. None of this is a recommendation to choose a format yourself.

Question Pre-mixed BPC 157 TB 500 blend Two separate vials
Handling One vial, one draw Two vials to store, label and draw from
Ratio between peptides Fixed when the vial is made Each can be set separately
Adjusting one peptide Changing one changes both A provider can change or stop one without the other
Combined stability data No published data we could verify Each peptide is handled on its own terms
Checking what is inside Harder: two identities and two amounts in one test Each vial can be tested separately

Flexibility is the point most people miss. If a provider wants to adjust or pause one peptide, a fixed blend makes that harder; with two vials, each part can move on its own. How providers think about the amounts is covered in our guide to Wolverine stack dosage.

Not sure whether the stack makes sense for you? That is a question for a licensed provider. telos rx supplies it as two separate vials. Plans are $133 per month, subject to medical approval by a licensed provider.

Start your provider review

Quality concerns with grey-market BPC 157 TB 500 blend vials

Most pre-mixed blends online are sold as "research use only," which means the seller says they are not made for people. With one peptide you already cannot confirm identity, strength or sterility. A blend doubles the problem.

  • Two identities to confirm. Both peptides need to be present, and neither swapped for something cheaper.
  • Two amounts to confirm. A label that says 5 mg + 5 mg tells you nothing unless someone measured both.
  • Sterility and contaminants. Any injectable needs sterile preparation.

These concerns are not hypothetical. A 2026 narrative review in the Journal of the American Academy of Orthopaedic Surgeons noted concerns about identity, purity, concentration, sterility and manufacturing consistency in commercial BPC-157 and TB-500 products. A 2026 review in Missouri Medicine on unregulated injectable peptides lists contamination, manufacturing impurities and inaccurate dosing among the risks. If you do have a certificate of analysis in front of you, our guide on how to read a peptide COA shows what to look for, and compounded vs unregulated sourcing explains the wider difference.

How a compounding pharmacy prepares a prescribed stack

A prescribed BPC-157 and TB-500 stack follows a different path from a grey-market blend. In general terms:

  1. A licensed provider reviews your intake and decides whether the stack is appropriate at all. Approval is not guaranteed.
  2. The prescription names you, the preparation and the directions. It is not a generic product.
  3. A licensed US pharmacy compounds it under its own procedures for sterile preparation, ingredient sourcing and labelling.
  4. Two vials, with dating set by the pharmacy. The telos rx stack is supplied as two separate vials, one of BPC-157 and one of TB-500. How long each vial is dated for use is a pharmacy and prescriber decision based on what they can support.
  5. You get patient-specific directions from your prescriber and a care team you can message if something changes.

Where the research stands on BPC-157 and TB-500 together

Very little research has looked at the combination at all. One 2026 rat study of repaired Achilles tendons compared BPC-157, TB-500 and the two combined over four weeks. The authors reported that the combination did not confer additional benefits over either peptide alone in that model. It is one small animal study, but a useful reminder that "two peptides" does not automatically mean "more effect."

Human evidence is thinner still. A 2026 primer in the American Journal of Sports Medicine concluded that indications, dosing, frequency and duration of treatment remain unknown for these peptides. For TB-500, human data are essentially absent. Whether a BPC 157 TB 500 blend or two vials is used, the evidence gap is the same.

Safety, regulation and sport

  • Not FDA-approved. BPC-157 is not FDA-approved, and TB-500 is not FDA-approved, for any use.
  • Regulatory status. In July 2026 the FDA's Pharmacy Compounding Advisory Committee voted to recommend adding both to the list of bulk substances that can be used in compounding (8 for, 6 against, 1 abstention). The vote was non-binding. On October 28, 2026, HHS announced an interim enforcement discretion policy covering compounded BPC-157 and compounded TB-500, each as a single-ingredient product, with a valid prescription and under strict conditions, while FDA decides through rulemaking. It does not cover the two blended in one vial, so a two-vial protocol is the format that fits the policy. It is temporary, it is not FDA approval, and HHS can revisit it. The telos rx stack is supplied as two separate vials, so neither vial is a blend. More in our TB-500 regulatory status update.
  • Side effects. Reported or theorised: injection-site reactions, headache, nausea, dizziness, fatigue, flushing. Long-term human safety is not established. See our guide to Wolverine stack side effects.
  • Cancer history, pregnancy and breastfeeding. Both are studied for angiogenesis, so people with cancer or a cancer history are commonly advised to avoid them. Not for pregnancy or breastfeeding. A provider decides.
  • Tested athletes. Both are on the WADA Prohibited List at all times. If you are subject to drug testing, read our WADA status guide first.

How the BPC-157 + TB-500 stack works at telos rx

telos rx supplies the BPC-157 + TB-500 stack as two separate vials, one of BPC-157 and one of TB-500, each a single-ingredient compounded, subcutaneous product. Your provider sets one plan covering both vials, including how each one is used. telos rx does not offer TB-500 on its own, and does not sell grey-market blends.

  • An online intake, reviewed asynchronously by a US-licensed provider, with no scheduled appointment.
  • A prescription is required and every plan is subject to medical approval by a licensed provider.
  • Each vial is compounded by a licensed US pharmacy and dispensed ready to inject at the dose your provider prescribed, so there is nothing to mix and no dose to calculate. The labels and your care team explain how to use and store them.
  • Secure care-team messaging; plans can be paused or cancelled. The stack is $133 per month, with details on the BPC-157 + TB-500 page.

Once you are on a protocol, the next question is usually duration. Our sibling guide on how long a BPC-157 + TB-500 cycle runs covers what providers weigh.

Skip the guesswork about what is in a mixed vial. A licensed provider reviews your intake online and decides whether the BPC-157 + TB-500 stack fits your health history.

See if the BPC-157 + TB-500 stack is right for you

Frequently asked questions

Is a BPC 157 TB 500 blend better than two separate vials?

Neither format has been shown to be better. No published study has compared a pre-mixed BPC 157 TB 500 blend with two separate vials in people. One vial is simpler to handle, while two vials let a provider adjust each peptide on its own. telos rx supplies its stack as two separate vials.

Is a BPC 157 TB 500 blend stable once mixed?

There is no published, peer-reviewed stability data for BPC-157 and TB-500 combined in one vial that we could verify. Stability depends on the specific formulation, diluent, container and storage, which is why a pharmacy, not a forum, should decide how long a preparation is dated for use. The telos rx stack is supplied as two separate vials, so the two peptides do not share one.

What is the Wolverine blend?

Wolverine blend, or Wolverine stack, is a popular nickname for BPC-157 and TB-500 used together. The name is marketing shorthand, not a medical term, and it does not describe a standard formula, ratio or dose.

Can I mix BPC-157 and TB-500 in the same syringe myself?

That is not something to decide on your own. Combining injectable peptides outside a pharmacy raises sterility, compatibility and dose-accuracy questions you cannot check at home. The telos rx stack arrives as two separate vials, each ready to inject at the prescribed dose, so there is nothing for you to mix. Your provider sets how each one is used. Follow only the directions your prescriber and pharmacy give you.

Why are grey-market bpc157 tb500 blend vials a concern?

Vials sold as "research use only" are not made for human use. Published reviews flag uncertainty about identity, purity, concentration and sterility in commercial peptide products. With a blend you also cannot confirm how much of each peptide is inside, or whether both are present at all.

Is the BPC-157 and TB-500 stack FDA-approved?

No. BPC-157 is not FDA-approved and TB-500 is not FDA-approved for any use. In July 2026 an FDA advisory committee voted to recommend adding both to the list of bulk substances that can be used in compounding. That vote was advisory and non-binding. On October 28, 2026, HHS announced a temporary enforcement discretion policy that covers each peptide as a single-ingredient compounded product under strict conditions, not a blend of the two in one vial. It is not FDA approval. The telos rx stack is supplied as two separate vials, so neither vial is a blend.

Does telos rx offer TB-500 on its own?

No. telos rx does not offer TB-500 on its own. It is only prescribed as part of the BPC-157 + TB-500 stack, supplied as two separate compounded subcutaneous vials at $133 per month, subject to medical approval by a licensed provider.

This article is for general education and is not medical advice, a dosing recommendation or a protocol. BPC-157 and TB-500 are not FDA-approved for any use. Compounded medications are not FDA-approved. All prescriptions are subject to medical approval by a licensed provider; approval is not guaranteed. Both peptides are prohibited in sport by WADA. Individual experiences vary. telos rx is an online-first, asynchronous telehealth service.

Related research

Compounded medications are compounded, not FDA-approved. Prescriptions are never automatic or guaranteed. TelosRX operates under LegitScript-certified telehealth standards as an online-first, asynchronous telehealth service.

Read more from TelosRX